Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2019

    2019 World Conference on Lung Cancer

    Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain

    Presentation Date(s):  
    • Sept 7 - 10, 2019
    • Total Presentations: 2848

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Advanced NSCLC

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Advanced NSCLC
    • Presentations: 0
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.01-107 - KEYNOTE-495/KeyImPaCT: Phase 2 Biomarker-Directed Study of Pembrolizumab-Based Therapy for Non–Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Martin Gutierrez

      • Abstract

      Loading...

    • +

      P1.01-112 - Phase 3, Randomized, Double-Blind Trial of First-Line Pembrolizumab With or Without Lenvatinib in Metastatic NSCLC: LEAP-007

      09:45 - 09:45  |  Presenter: Tarek Mekhail

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.01-118 - Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study

      09:45 - 09:45  |  Presenter: Maximilian J. Hochmair

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA09 - EGFR & MET

    • Type: Mini Oral Session
    • Track: Targeted Therapy
    • Presentations: 1
    • Now Available
    • Moderators:Jordi Remon
    • Coordinates: 9/08/2019, 15:15 - 16:45, Melbourne (1991)
    • +

      MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up (Now Available)

      16:15 - 16:20  |  Presenter: Yi-Long Wu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA04 - Immuno Combinations and the Role of TMB

    • Type: Oral Session
    • Track: Immuno-oncology
    • Presentations: 1
    • Now Available
    • Moderators:Solange Peters
    • Coordinates: 9/08/2019, 15:15 - 16:45, Copenhagen (1980)
    • +

      OA04.05 - KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC (Now Available)

      16:00 - 16:10  |  Presenter: Corey Jay Langer

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.01 - Advanced NSCLC

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Advanced NSCLC
    • Presentations: 0
    • Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
    • +

      P2.01-02 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC

      10:15 - 10:15  |  Presenter: Edward Garon

      • Abstract

      Loading...

    • +

      P2.01-39 - Serial Plasma ctDNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in T790M+ NSCLC

      10:15 - 10:15  |  Presenter: Bin-Chi Liao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.14 - Targeted Therapy

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Targeted Therapy
    • Presentations: 0
    • Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
    • +

      P2.14-20 - ATORG-003: Dacomitinib With or Without Dose Titration as First-Line Therapy for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

      10:15 - 10:15  |  Presenter: Aaron C Tan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P2.14-60 - Afatinib in EGFR Mutation-Positive NSCLC: Activity in Patients with Brain Metastases, and Impact on CNS Progression/Spread

      10:15 - 10:15  |  Presenter: Kenneth John O’Byrne

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ES18 - Acquired Resistance to TKIs: The Rebiopsy Case and the Future Options

    • Type: Educational Session
    • Track: Targeted Therapy
    • Presentations: 1
    • Now Available
    • Moderators:Teresa Moran
    • Coordinates: 9/09/2019, 11:00 - 12:30, Vienna (2016)
  • +

    OA11 - Decomplexifying Molecular Targets, Immunotherapy and Treatment Settings in the Real World

    • Type: Oral Session
    • Track: Treatment in the Real World - Support, Survivorship, Systems Research
    • Presentations: 1
    • Now Available
    • Moderators:Kumar Prabhash
    • Coordinates: 9/09/2019, 14:00 - 15:30, Interlaken (1988)
  • +

    PC03 - Adjuvant Therapy for Resected NSCLC Harboring EGFR Mutation, Chemotherapy or Targeted Therapy

    • Type: Pro-Con Session
    • Track: Targeted Therapy
    • Presentations: 4
    • Now Available